AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen P/E ratio

Amgen's P/E ratio is 26.63: its share price of 462.90 over its earnings per share of 17.38 over the last twelve months.

Today
26.63
Forward P/E, next 12 months
18.64
PEG ratio
1.57
Median, 5 years
23.75
Low, 5 years
14.47
High, 5 years
57.77

P/E ratio = price ÷ EPS (last 12 months) = 462.90 ÷ 17.38 = 26.63

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Amgen's P/E high compared with its own history?

Amgen's P/E of 26.6 is above the middle of its 5-year range (14.5 to 57.8, median 23.7). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202718.49———
FY2026 · Estimate31 Dec 202619.66———
Today26.6318.64250.39B9.39B
FY202531 Dec 202522.8413.90176.09B7.71B
FY202431 Dec 202434.4812.23141.01B4.09B
FY202331 Dec 202322.9414.70154.09B6.72B
FY202231 Dec 202221.5714.15141.30B6.55B
FY202131 Dec 202121.7612.73128.23B5.89B
FY202031 Dec 202018.5513.66134.73B7.26B
FY201931 Dec 201918.6014.99145.85B7.84B
FY201831 Dec 201815.3313.32128.68B8.39B
FY201731 Dec 201764.2312.19127.12B1.98B
FY201631 Dec 201614.1611.52109.37B7.72B
FY201531 Dec 201517.7314.05123.05B6.94B
FY201431 Dec 201423.4415.80120.90B5.16B
FY201331 Dec 201316.9114.9385.90B5.08B
FY201231 Dec 201215.3813.3666.81B4.35B
FY201131 Dec 201115.7812.4258.11B3.68B
FY201031 Dec 201011.3911.3452.70B4.63B
FY200931 Dec 200912.4812.2757.48B4.61B
FY200831 Dec 200814.7312.8661.79B4.20B
FY200731 Dec 200716.3812.0051.87B3.17B
FY200631 Dec 200627.2317.0980.33B2.95B
FY200531 Dec 200526.5321.8097.47B3.67B
FY200431 Dec 200434.5023.4181.53B2.36B
FY200331 Dec 200335.2226.2979.59B2.26B
FY200231 Dec 2002—27.1655.76B-1.39B
FY200131 Dec 200152.7043.7559.01B1.12B
FY200031 Dec 200057.8257.1265.83B1.14B
FY199931 Dec 199955.9758.8861.36B1.10B
FY199831 Dec 199830.8930.4026.67B863.20M
FY199731 Dec 199722.1819.6114.29B644.30M
FY199631 Dec 199622.4519.9915.26B679.80M
FY199531 Dec 199530.99—16.66B537.70M
FY199431 Dec 199425.82—8.25B319.70M
FY199331 Dec 199318.10—6.78B374.60M
FY199231 Dec 199228.48—10.19B357.60M
FY199131 Dec 1991105.22—10.30B97.90M
FY199031 Dec 199048.07—1.65B34.30M
FY198931 Dec 19890.00—0.0019.10M
FY198831 Dec 1988——576.56M-8.20M
FY198731 Dec 1987357.43—607.63M1.70M
FY198631 Dec 1986542.09—433.67M800.00K
FY198531 Dec 1985326.76—163.38M500.00K

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Amgen's P/E ratio

Source: Financial Modeling PrepVerified against SEC filings